Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · IEX Real-Time Price · USD
5.42
-0.24 (-4.24%)
At close: May 31, 2024, 4:00 PM
5.51
+0.09 (1.66%)
After-hours: May 31, 2024, 6:23 PM EDT
Sensus Healthcare Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Sensus Healthcare stock have an average target of 10, which predicts an increase of 84.50% from the current stock price of 5.42.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SRTS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +84.50% | May 13, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +84.50% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +47.60% | Nov 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +47.60% | Aug 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 → $10 | Strong Buy | Reiterates | $16 → $10 | +84.50% | May 4, 2023 |
Financial Forecast
Revenue This Year
35.21M
from 24.41M
Increased by 44.29%
Revenue Next Year
41.92M
from 35.21M
Increased by 19.05%
EPS This Year
0.30
from 0.03
Increased by 886.00%
EPS Next Year
0.48
from 0.30
Increased by 63.79%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 36.5M | 43.8M | 40.8M |
| Avg | 35.2M | 41.9M | 39.7M |
| Low | 33.6M | 39.7M | 38.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 49.6% | 24.4% | -2.6% |
| Avg | 44.3% | 19.1% | -5.4% |
| Low | 37.6% | 12.7% | -9.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.30 | 0.50 | 0.38 |
| Avg | 0.30 | 0.48 | 0.37 |
| Low | 0.28 | 0.46 | 0.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 915.0% | 70.4% | -22.0% |
| Avg | 886.0% | 63.8% | -24.2% |
| Low | 847.3% | 55.7% | -27.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.